Keck Medicine of USC enrolling patients as part of international clinical trial to study antiviral drug as treatment for COVID-19

(University of Southern California - Health Sciences) Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19.